Welcome to your Daily Dose of Health Tech Innovation!
Stay ahead with the latest breakthroughs revolutionizing healthcare—from AI diagnostics to remote care solutions.
We bring you expert-curated insights, emerging trends, and must-know updates from the digital health frontier.
Whether you’re a clinician, innovator, or health tech enthusiast, this roundup delivers what matters most.
Let’s dive into the future of health, one innovation at a time.
Artera Secures $65Million Growth Investment and Reaches $100Million CARR
Artera.io, combining human and AI agent intelligence to fix patient communications, announces a $65 million growth investment and a major milestone of reaching $100 million in Contracted Annual Recurring Revenue (CARR) by the end of 2025. Healthcare organizations have used Artera’s AI solutions to engage more than 200 million patients. With over 1,000 healthcare organization customers, including specialty groups, FQHCs, healthcare providers, and federal agencies, Artera supports over 2 billion patient-to-provider communications annually.
MHK Launches SmartProminence AI Solutions
MHK, a leading healthcare technology provider and part of the Hearst Health network, announced the launch of its SmartProminence solution suite. Featuring AI-powered capabilities across MHK’s platform, with initial focus on Utilization Management (UM), Complaints, Appeals & Grievances (CAG), and Pharmacy Management solutions, SmartProminence is designed to help health plans and pharmacy benefit managers more efficiently achieve operational excellence, ensure compliance, and deliver better outcomes for members.
PAICON Advances Global Cancer AI With Diverse Data
The gap in data diversity has long been one of the most serious weaknesses in modern medicine, particularly in oncology, where clinical decisions often depend on patterns found in large datasets. PAICON, a young healthtech company rooted in artificial intelligence and cancer research, has stepped directly into this problem with the goal of building cancer diagnostics that work for the entire world rather than only for the populations that existing models tend to reflect. According to Dr Manasi A Ratnaparkhe, CEO and co founder of PAICON, most cancer AI systems presently rely on datasets drawn primarily from Western countries, which cover only a small portion of the global population. She explains that the majority of people worldwide remain unrepresented, and that this lack of diversity contributes to missed diagnoses and avoidable harm. She describes PAICON’s mission as an effort to correct this imbalance and bring more fairness and accuracy to cancer diagnostics.
GE HealthCare Launches Imaging 360 Powered By AI to Improve Operations Efficiency
GE HealthCare has introduced the latest updates to its Imaging 360 platform, now enhanced with artificial intelligence designed to improve efficiency in radiology departments. The AI-powered Discoveries feature helps balance device usage, optimize scheduling, and identify opportunities to standardize imaging protocols. These advancements aim to give healthcare teams more time and energy to focus on patient care, enabling hospitals to serve more patients effectively with existing resources.
Taiho Oncology Launches Lytgobi for Cholangiocarcinoma UK
Taiho Oncology Europe has announced the launch of Lytgobi (futibatinib) in the United Kingdom for adult patients with locally advanced or metastatic cholangiocarcinoma who have already received at least one line of systemic therapy. The launch follows the conditional marketing authorization granted in September 2024 and a subsequent recommendation from the National Institute for Health and Care Excellence, supporting futibatinib monotherapy as a treatment option for patients with FGFR2 fusions or rearrangements.
To share your insights, please write to us at sudipto@intentamplify.com
